Balasa Dinverno & Foltz’s Novo Nordisk NVO Stock Holding History

Balasa Dinverno & Foltz’s Portfolio NVO Stock Details NVO Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$316K	Buy
2022 Q2	$350K	Buy
2022 Q1	$345K	Sell
2021 Q4	$355K	Buy
2021 Q3	$299K	Buy
2021 Q2	$251K	Buy